![Hendrik Nogai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 106 705 $ al 31/08/2026
Dr. Hendrik Nogai, MD, is a Chief Medical Officer at Ryvu Therapeutics SA. Dr. Nogai was previously employed as a Vice President by Bayer Pharmaceuticals /Switzerland/.
He received his doctorate degree from Ludwig-Maximilians-Universität München, a doctorate degree from Charité - Universitätsmedizin Berlin and a doctorate degree from Harvard Medical School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
RYVU THERAPEUTICS SA 0,1 % | 30/09/2025 | 22.500 ( 0,1 % ) | 106 705 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Director Técnico/Científico/I+D | 01/02/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Bayer Pharmaceuticals /Switzerland/ | Corporate Officer/Principal | 01/01/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Charité - Universitätsmedizin Berlin
 Charité - Universitätsmedizin Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ryvu Therapeutics SA
 Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology | Health Technology |
Bayer Pharmaceuticals /Switzerland/ |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
